Wound Care

Orthopaedics faculty at LSU Health New Orleans participated in a study comparing two antisepsis aqueous solutions in reducing the risk of infection in patients requiring surgery for open fractures. In the largest known randomized-controlled trial, the research team found that contrary to current international recommendations, chlorhexidine gluconate was not superior to povidone-iodine in an alcohol
0 Comments
Even months after critical illness for sepsis, children are at risk for new or worsening medical conditions, a study suggests. One in five children in a national cohort either developed or experienced progressing disease within six months of leaving the intensive care unit for sepsis, according to the research in JAMA Pediatrics. Researchers compared data
0 Comments
From LabskinSep 27 2022Reviewed by Maria Osipova Labskin and University of Bradford team up to bring new science in skin health to greater diversity for skin types. Pictured below from left to right: Dr Sobia Kauser, Assistant Professor University of Bradford, Dr. David Caballero-Lima, Chief Scientist Labskin, Dr. Jacobo Elies Gomez, Assistant Professor, University of
0 Comments
The study, which includes the first resource detailing the role of microRNAs in the wound-repair process, shows that aberrant levels of a trio of microRNAs may impair healing in venous ulcers. The findings suggest that drugs targeting these microRNAs could help facilitate healing in patients. Venous ulcers commonly occur in the legs, caused by poor
0 Comments
A new clinical-grade collagen made from discarded bullfrog skin is leapfrogging from the lab bench to clinics soon. The collagen is developed by materials scientists from Nanyang Technological University, Singapore (NTU Singapore) in collaboration with Singapore medical technology firm Cuprina Wound Care Solutions (Cuprina), which specializes in developing products that treat chronic wounds, such as
0 Comments
The American Society of Colon and Rectal Surgeons has issued updated guidelines for physicians, published in Diseases of the Colon & Rectum, about how to treat problems of the anus and rectum called anorectal abscess, anal fistula, and rectovaginal fistula. The journal is published in the Lippincott portfolio by Wolters Kluwer. The guidelines were prepared
0 Comments
The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine technology that achieves functional tissue reprogramming in the live body. Last year, ICRME researchers published on how to manufacture the TNT 2.0 silicon chip hardware in Nature Protocol. Now, their research demonstrates
0 Comments
The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine technology that achieves functional tissue reprogramming in the live body. Last year, ICRME researchers published on how to manufacture the TNT 2.0 silicon chip hardware in Nature Protocol. Now, their research demonstrates
0 Comments
Antibiotic resistant bacterial pathogens are increasingly playing a role in rising illness and preventing wound healing, especially in hospitals. While more and more pathogens have developed biofilms that protect them from being eradicated by antibiotics, fewer classes of antibiotics are being developed. Researchers from Ben-Gurion University of the Negev decided to go in a different
0 Comments
Patients who undergo facial surgery think their surgical scars look worse than surgeons and independent observers do, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Surgeons and those not tied personally to the particular scarring felt similarly about how significant a scar appeared, but those who looked
0 Comments
Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs the survival of men with metastatic, hormone-sensitive prostate cancer, a disease that is fatal in most cases. The study, which was conducted by a team led by investigators at Massachusetts General
0 Comments